EKSO
Ekso Bionics Holdings Inc
Price Chart
No historical data available
Latest Quote
$11.80
+0.15 (+1.29%)
Current Price
| Previous Close | $11.65 |
| Open | $11.40 |
| Day High | $11.65 |
| Day Low | $11.65 |
| Volume | 95,135 |
Stock Information
| Shares Outstanding | 3.56M |
| Total Debt | $4.64M |
| Cash Equivalents | $1.17M |
| Revenue | $12.80M |
| Net Income | $-11.92M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $42.05M |
| EPS (TTM) | $-5.11 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $44.24M |
| Sales | $12.80M |
| Income | $-11.92M |
| Book/sh | $2.54 |
| Cash/sh | $0.33 |
| Employees | 50 |
Financial Ratios
| Quick Ratio | 0.98 |
| Current Ratio | 1.63 |
| Debt/Eq | 51.45 |
Returns & Margins
| ROA | -33.62% |
| ROE | -107.62% |
| Gross Margin | 53.48% |
| Operating Margin | -119.71% |
| Profit Margin | -91.37% |
Ownership
| Insider Ownership | 24.54% |
| Institutional Ownership | 26.74% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -62.11 |
| P/S | 3.29 |
| P/B | 4.65 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $10.56 |
| SMA50 | $10.65 |
| SMA200 | $6.83 |
| RSI | 69.14 |
| ATR | 0.8623 |
| Shares Float | 2.24M |
| Short Float | 7.30% |
| Short Ratio | 3.28 |
| Volatility | 0.78 |
| Rel Volume | 1.73 |
Performance History
| Week | +2.46% |
| Month | +23.94% |
| Quarter | +24.33% |
| 6 Months | +128.43% |
| YTD | +48.60% |
| Year | +60.53% |
| 3 Years | -46.06% |
| 5 Years | -86.25% |
| 10 Years | -98.73% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
No history data available. Data will be fetched automatically.
About Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
đ° Latest News
Applied Digital (APLD) Completes Cloud, Data Center Separation, Soars 12%
Insider Monkey âĸ 2026-05-06T01:23:41Z
Applied Digital Forms New Company to Boost AI-Cloud Business
IPO-Edge.com âĸ 2026-05-05T22:20:51Z
Jim Cramer on Applied Digital: A $7.5 Billion Contract Isnât Enough Without Profits
24/7 Wall St. âĸ 2026-05-03T15:11:42Z
Applied Digital Reshapes AI Cloud And Debt Profile With ChronoScale Move
Simply Wall St. âĸ 2026-03-29T13:03:11Z
Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates
Zacks âĸ 2026-02-26T13:15:06Z
Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?
Zacks âĸ 2026-02-17T14:40:02Z
How The Ekso Bionics Holdings Narrative Is Shifting After Q3 And A Higher Price Target
Simply Wall St. âĸ 2026-02-11T19:09:45Z
How The New Price Target Is Shaping Ekso Bionics Holdings (EKSO) Story
Simply Wall St. âĸ 2026-01-27T13:10:41Z
How Recent Developments Are Rewriting The Story For Ekso Bionics Holdings (EKSO)
Simply Wall St. âĸ 2026-01-12T12:11:51Z
Arete Research Initiates Applied Digital (APLD) with $99 PT, Buy Rating
Insider Monkey âĸ 2026-01-09T11:31:30Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $5,954,000 | $8,414,000 | $9,200,000 | $6,698,000 |
| Cost Of Revenue | $5,954,000 | $8,414,000 | $9,200,000 | $6,698,000 |
| Total Revenue | $12,799,000 | $17,925,000 | $18,279,000 | $12,912,000 |
| Operating Revenue | $12,517,000 | $16,971,000 | $17,920,000 | $11,919,000 |
| Expenses | ||||
| Interest Expense | $309,000 | $269,000 | $302,000 | $156,000 |
| Total Expenses | $26,125,000 | $28,385,000 | $33,391,000 | $28,468,000 |
| Other Income Expense | $1,940,000 | $-601,000 | $216,000 | $632,000 |
| Other Non Operating Income Expenses | $-26,000 | $-1,000 | $-63,000 | $-30,000 |
| Net Non Operating Interest Income Expense | $-309,000 | $-269,000 | $-302,000 | $-156,000 |
| Interest Expense Non Operating | $309,000 | $269,000 | $302,000 | $156,000 |
| Operating Expense | $20,171,000 | $19,971,000 | $24,191,000 | $21,770,000 |
| Selling And Marketing Expense | $7,154,000 | $7,308,000 | $8,472,000 | $7,157,000 |
| General And Administrative Expense | $9,986,000 | $8,789,000 | $10,694,000 | $10,987,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-11,695,000 | $-11,330,000 | $-15,198,000 | $-15,080,000 |
| Net Interest Income | $-309,000 | $-269,000 | $-302,000 | $-156,000 |
| Normalized Income | $-13,661,000 | $-10,730,000 | $-15,477,000 | $-15,742,000 |
| Net Income From Continuing And Discontinued Operation | $-11,695,000 | $-11,330,000 | $-15,198,000 | $-15,080,000 |
| Total Operating Income As Reported | $-13,326,000 | $-10,460,000 | $-15,112,000 | $-15,556,000 |
| Net Income Common Stockholders | $-11,695,000 | $-11,330,000 | $-15,198,000 | $-15,080,000 |
| Net Income | $-11,695,000 | $-11,330,000 | $-15,198,000 | $-15,080,000 |
| Net Income Including Noncontrolling Interests | $-11,695,000 | $-11,330,000 | $-15,198,000 | $-15,080,000 |
| Net Income Continuous Operations | $-11,695,000 | $-11,330,000 | $-15,198,000 | $-15,080,000 |
| Pretax Income | $-11,695,000 | $-11,330,000 | $-15,198,000 | $-15,080,000 |
| Operating Income | $-13,326,000 | $-10,460,000 | $-15,112,000 | $-15,556,000 |
| Gross Profit | $6,845,000 | $9,511,000 | $9,079,000 | $6,214,000 |
| Average Dilution Earnings | - | - | - | $0 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-4.91 | $-8.40 | $-16.50 | $-17.40 |
| Basic EPS | $-4.91 | $-8.40 | $-16.50 | $-17.40 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-11,779,000 | $-8,853,000 | $-13,477,000 | $-14,699,000 |
| Total Unusual Items | $1,966,000 | $-600,000 | $279,000 | $662,000 |
| Total Unusual Items Excluding Goodwill | $1,966,000 | $-600,000 | $279,000 | $662,000 |
| Reconciled Depreciation | $1,573,000 | $1,608,000 | $1,698,000 | $887,000 |
| EBITDA (Bullshit earnings) | $-9,813,000 | $-9,453,000 | $-13,198,000 | $-14,037,000 |
| EBIT | $-11,386,000 | $-11,061,000 | $-14,896,000 | $-14,924,000 |
| Diluted Average Shares | $2,426,000 | $1,344,066 | $924,466 | $864,133 |
| Basic Average Shares | $2,426,000 | $1,344,066 | $924,466 | $864,133 |
| Diluted NI Availto Com Stockholders | $-11,695,000 | $-11,330,000 | $-15,198,000 | $-15,080,000 |
| Gain On Sale Of Security | $1,966,000 | $-600,000 | $279,000 | $662,000 |
| Research And Development | $3,031,000 | $3,874,000 | $5,025,000 | $3,626,000 |
| Selling General And Administration | $17,140,000 | $16,097,000 | $19,166,000 | $18,144,000 |
| Other Gand A | $9,986,000 | $8,789,000 | $10,694,000 | $10,987,000 |
| Other Special Charges | - | - | - | - |
| Impairment Of Capital Assets | - | - | - | - |
| Restructuring And Mergern Acquisition | - | - | - | - |
Fetched: 2026-05-02
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $5,096,000 | $7,696,000 | $7,283,000 | $19,794,000 |
| Total Assets | $20,111,000 | $26,652,000 | $28,918,000 | $40,903,000 |
| Total Non Current Assets | $6,062,000 | $7,809,000 | $8,709,000 | $9,866,000 |
| Other Non Current Assets | $311,000 | $433,000 | $392,000 | $231,000 |
| Goodwill And Other Intangible Assets | $3,931,000 | $5,011,000 | $5,323,000 | $5,648,000 |
| Other Intangible Assets | $3,500,000 | $4,580,000 | $4,892,000 | $5,217,000 |
| Current Assets | $14,049,000 | $18,843,000 | $20,208,000 | $31,037,000 |
| Other Current Assets | $750,000 | $541,000 | $875,000 | $700,000 |
| Restricted Cash | $0 | $2,000,000 | - | - |
| Inventory | $4,822,000 | $4,571,000 | $5,050,000 | $5,187,000 |
| Receivables | $7,308,000 | $7,238,000 | $5,645,000 | $4,625,000 |
| Accounts Receivable | $7,308,000 | $7,238,000 | $5,645,000 | $4,625,000 |
| Allowance For Doubtful Accounts Receivable | $-27,000 | $-33,000 | $-79,000 | $-40,000 |
| Gross Accounts Receivable | $7,335,000 | $7,271,000 | $5,724,000 | $4,665,000 |
| Cash Cash Equivalents And Short Term Investments | $1,169,000 | $4,493,000 | $8,638,000 | $20,525,000 |
| Cash And Cash Equivalents | $1,169,000 | $4,493,000 | $8,638,000 | $20,525,000 |
| Cash Financial | $1,169,000 | $4,493,000 | $8,638,000 | $20,525,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $2,887,000 | $611,000 | - | - |
| Total Debt | $4,644,000 | $5,983,000 | $7,168,000 | $7,505,000 |
| Long Term Debt And Capital Lease Obligation | $945,000 | $4,306,000 | $5,555,000 | $4,854,000 |
| Long Term Debt | $798,000 | $3,854,000 | $4,832,000 | $3,767,000 |
| Current Debt And Capital Lease Obligation | $3,699,000 | $1,677,000 | $1,613,000 | $2,651,000 |
| Current Debt | $3,258,000 | $1,250,000 | $1,250,000 | $2,310,000 |
| Other Current Borrowings | $3,258,000 | $1,250,000 | $1,250,000 | $2,310,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $11,084,000 | $13,945,000 | $16,312,000 | $15,461,000 |
| Total Non Current Liabilities Net Minority Interest | $2,448,000 | $6,408,000 | $8,195,000 | $6,260,000 |
| Other Non Current Liabilities | $89,000 | $181,000 | $105,000 | $141,000 |
| Derivative Product Liabilities | $0 | $1,000 | $366,000 | $233,000 |
| Non Current Deferred Liabilities | $1,414,000 | $1,920,000 | $2,169,000 | $1,032,000 |
| Current Liabilities | $8,636,000 | $7,537,000 | $8,117,000 | $9,201,000 |
| Current Deferred Liabilities | $1,727,000 | $1,956,000 | $1,993,000 | $1,121,000 |
| Payables And Accrued Expenses | $3,210,000 | $3,904,000 | $4,511,000 | $5,429,000 |
| Payables | $1,431,000 | $1,552,000 | $1,847,000 | $3,151,000 |
| Accounts Payable | $1,431,000 | $1,552,000 | $1,847,000 | $3,151,000 |
| Equity | ||||
| Common Stock Equity | $9,027,000 | $12,707,000 | $12,606,000 | $25,442,000 |
| Total Equity Gross Minority Interest | $9,027,000 | $12,707,000 | $12,606,000 | $25,442,000 |
| Stockholders Equity | $9,027,000 | $12,707,000 | $12,606,000 | $25,442,000 |
| Gains Losses Not Affecting Retained Earnings | $-692,000 | $957,000 | $156,000 | $563,000 |
| Other Equity Adjustments | $-692,000 | $957,000 | $156,000 | $563,000 |
| Retained Earnings | $-262,396,000 | $-250,475,000 | $-239,145,000 | $-223,947,000 |
| Other | ||||
| Ordinary Shares Number | $3,559,000 | $1,480,200 | $989,866 | $880,200 |
| Share Issued | $3,559,000 | $1,480,200 | $989,866 | $880,200 |
| Tangible Book Value | $5,096,000 | $7,696,000 | $7,283,000 | $19,794,000 |
| Invested Capital | $13,083,000 | $17,811,000 | $18,688,000 | $31,519,000 |
| Working Capital | $5,413,000 | $11,306,000 | $12,091,000 | $21,836,000 |
| Capital Lease Obligations | $588,000 | $879,000 | $1,086,000 | $1,428,000 |
| Total Capitalization | $9,825,000 | $16,561,000 | $17,438,000 | $29,209,000 |
| Additional Paid In Capital | $272,078,000 | $262,203,000 | $251,580,000 | $248,813,000 |
| Capital Stock | $37,000 | $22,000 | $15,000 | $13,000 |
| Common Stock | $37,000 | $22,000 | $15,000 | $13,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $1,414,000 | $1,920,000 | $2,169,000 | $1,032,000 |
| Long Term Capital Lease Obligation | $147,000 | $452,000 | $723,000 | $1,087,000 |
| Current Deferred Revenue | $1,727,000 | $1,956,000 | $1,993,000 | $1,121,000 |
| Current Capital Lease Obligation | $441,000 | $427,000 | $363,000 | $341,000 |
| Current Accrued Expenses | $1,779,000 | $2,352,000 | $2,664,000 | $2,278,000 |
| Goodwill | $431,000 | $431,000 | $431,000 | $431,000 |
| Net PPE | $1,820,000 | $2,365,000 | $2,994,000 | $3,987,000 |
| Accumulated Depreciation | $-3,754,000 | $-3,341,000 | $-3,156,000 | $-2,997,000 |
| Gross PPE | $5,574,000 | $5,706,000 | $6,150,000 | $6,984,000 |
| Leases | $194,000 | $194,000 | $178,000 | $142,000 |
| Other Properties | $2,032,000 | $2,212,000 | $2,395,000 | $2,654,000 |
| Machinery Furniture Equipment | $3,348,000 | $3,300,000 | $3,577,000 | $4,330,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,127,000 | $843,000 | $462,000 | $863,000 |
| Work In Process | $102,000 | $177,000 | $290,000 | $487,000 |
| Raw Materials | $3,593,000 | $3,551,000 | $4,298,000 | $3,837,000 |
| Treasury Shares Number | - | - | $0 | - |
Fetched: 2026-05-02
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-11,989,000 | $-9,883,000 | $-12,211,000 | $-14,882,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-11,801,000 | $-9,846,000 | $-12,054,000 | $-14,688,000 |
| Cash Flow From Continuing Operating Activities | $-11,801,000 | $-9,846,000 | $-12,054,000 | $-14,688,000 |
| Operating Gains Losses | $-1,966,000 | $600,000 | $-279,000 | $-662,000 |
| Investing Activities | ||||
| Capital Expenditure | $-188,000 | $-37,000 | $-157,000 | $-194,000 |
| Investing Cash Flow | $-188,000 | $-37,000 | $-157,000 | $-5,175,000 |
| Cash Flow From Continuing Investing Activities | $-188,000 | $-37,000 | $-157,000 | $-5,175,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,098,000 | $9,019,000 | $661,000 | $0 |
| Financing Cash Flow | $6,629,000 | $7,769,000 | $348,000 | $0 |
| Cash Flow From Continuing Financing Activities | $6,629,000 | $7,769,000 | $348,000 | $0 |
| Net Common Stock Issuance | $4,098,000 | $9,019,000 | $661,000 | $0 |
| Common Stock Issuance | $4,098,000 | $9,019,000 | $661,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-3,250,000 | $-1,250,000 | $-313,000 | $0 |
| Issuance Of Debt | $1,925,000 | $0 | - | - |
| Interest Paid Supplemental Data | $118,000 | $182,000 | $191,000 | $126,000 |
| Income Tax Paid Supplemental Data | $5,000 | $8,000 | $45,000 | $13,000 |
| End Cash Position | $1,169,000 | $6,493,000 | $8,638,000 | $20,525,000 |
| Beginning Cash Position | $6,493,000 | $8,638,000 | $20,525,000 | $40,406,000 |
| Effect Of Exchange Rate Changes | $36,000 | $-31,000 | $-24,000 | $-18,000 |
| Changes In Cash | $-5,360,000 | $-2,114,000 | $-11,863,000 | $-19,863,000 |
| Proceeds From Stock Option Exercised | $3,856,000 | $0 | - | $0 |
| Net Issuance Payments Of Debt | $-1,325,000 | $-1,250,000 | $-313,000 | $0 |
| Net Long Term Debt Issuance | $-1,325,000 | $-1,250,000 | $-313,000 | $0 |
| Long Term Debt Payments | $-3,250,000 | $-1,250,000 | $-313,000 | $0 |
| Long Term Debt Issuance | $1,925,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-188,000 | $-37,000 | $-157,000 | $-175,000 |
| Purchase Of PPE | $-188,000 | $-37,000 | $-157,000 | $-194,000 |
| Change In Working Capital | $-2,038,000 | $-2,525,000 | $-583,000 | $-2,580,000 |
| Change In Other Working Capital | $-783,000 | $-257,000 | $1,992,000 | $-511,000 |
| Change In Payables And Accrued Expense | $-1,239,000 | $-887,000 | $-1,441,000 | $-299,000 |
| Change In Accrued Expense | $-1,102,000 | $-599,000 | $-134,000 | $-197,000 |
| Change In Payable | $-137,000 | $-288,000 | $-1,307,000 | $-102,000 |
| Change In Account Payable | $-137,000 | $-288,000 | $-1,307,000 | $-102,000 |
| Change In Prepaid Assets | $-187,000 | $329,000 | $-158,000 | $-303,000 |
| Change In Inventory | $-275,000 | $257,000 | $232,000 | $-1,400,000 |
| Change In Receivables | $446,000 | $-1,967,000 | $-1,208,000 | $-67,000 |
| Changes In Account Receivables | $446,000 | $-1,967,000 | $-1,208,000 | $-67,000 |
| Stock Based Compensation | $1,625,000 | $1,630,000 | $2,236,000 | $2,732,000 |
| Provisionand Write Offof Assets | $-50,000 | $171,000 | $72,000 | $33,000 |
| Asset Impairment Charge | $750,000 | $0 | - | - |
| Depreciation Amortization Depletion | $1,573,000 | $1,608,000 | $1,698,000 | $887,000 |
| Depreciation And Amortization | $1,573,000 | $1,608,000 | $1,698,000 | $887,000 |
| Gain Loss On Investment Securities | $-1,000 | $-365,000 | $133,000 | $-1,317,000 |
| Net Foreign Currency Exchange Gain Loss | $-1,965,000 | $965,000 | $-412,000 | $655,000 |
| Net Income From Continuing Operations | $-11,695,000 | $-11,330,000 | $-15,198,000 | $-15,080,000 |
| Net Business Purchase And Sale | - | - | $0 | $-5,000,000 |
| Purchase Of Business | - | - | $0 | $-5,000,000 |
| Sale Of PPE | - | - | $0 | $19,000 |
| Other Non Cash Items | - | - | - | $-18,000 |
| Depreciation | - | - | - | - |
Fetched: 2026-05-02